Testagen
Also known as KEDG, Anterior Pituitary Peptide (APP)
Testagen is a peptide bioregulator that restores youthful testosterone production by directly modulating pituitary gene expression to increase luteinizing hormone (LH) and thyroid-stimulating hormone (TSH) release, triggering downstream testosterone and thyroid hormone synthesis—addressing the root endocrine dysregulation underlying age-related hormone decline rather than supplying testosterone externally.
Route
Subcutaneous injection
Dose range
100 mcg – 300 mcg
Frequency
Once per day (subcutaneous)
Cycle length
8–12 weeks
Overview
Testagen is a peptide bioregulator that restores youthful testosterone production by directly modulating pituitary gene expression to increase luteinizing hormone (LH) and thyroid-stimulating hormone (TSH) release, triggering downstream testosterone and thyroid hormone synthesis—addressing the root endocrine dysregulation underlying age-related hormone decline rather than supplying testosterone externally.
Key distinction from testosterone replacement therapy: Testagen restores pituitary feedback loops and gene expression patterns, creating sustainable endogenous hormone production without suppressing the hypothalamic-pituitary-gonadal axis or requiring indefinite supplementation. Benefits span improved sexual function, libido, erectile quality, muscle mass and strength, bone density, metabolic rate, energy, mood, and cognitive clarity. The thyroid-stimulating function adds metabolic enhancement beyond testosterone alone. Applied via intramuscular injection (typically 5-20mg weekly), Testagen offers hormonal restoration without exogenous hormone dependency, ideal for aging men seeking natural hormone optimization.
Studied benefits
- A bioregulatory peptide studied for its potential to normalize thyroid function and modulate male reproductive hormones via the pituitary gland
Reported side effects
- No human clinical data is available, so the full safety profile is unknown
- Preclinical studies suggest it is well-tolerated with possible minor injection-site irritation
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
Testagen (20mg)
Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL).
Support endocrine function research, particularly pituitary–gonadal axis modulation and male reproductive health.
| Week | Daily Dose (mcg) | Draw at 6.67 mg/mL | Log |
|---|---|---|---|
| Weeks 1–2 | 100 mcg (0.1 mg) | 1.5 units (0.015 mL) | + Log |
| Weeks 3–4 | 150 mcg (0.15 mg) | 2.3 units (0.022 mL) | + Log |
| Weeks 5–8 | 200 mcg (0.2 mg) | 3 units (0.03 mL) | + Log |
| Weeks 9–12 | 250–300 mcg | 4.5 units (0.045 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Any consistent time; rotate injection sites.
Cycle length
8–12 weeks.
Unit calculator
Set your vial and water; the table above updates.
6.67 mg/mL
200 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 8-week cycle) you would use about 5.6 mg, i.e. 1 × 20 mg vial. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Follow a nutrient-dense, balanced diet rich in zinc, magnesium, and healthy fats to support the bioregulator's role in maintaining the structural integrity and functional health of the male reproductive system. Stay physically active with regular resistance training to maintain healthy testosterone levels and metabolic health, which complements the peptide’s goal of restoring testicular tissue homeostasis. Ensure 7–9 hours of quality sleep for optimal endocrine signaling and to manage systemic stress. Avoid alcohol and environmental toxins to minimize the oxidative load on reproductive tissues, allowing the peptide to effectively support cellular repair.
Evidence
Research summaries
Androgen Receptors in Epithelial Cells Regulate Thymopoiesis and Thymic Involution
Findings: Keeps the immune training center (thymus) working right and stops it from shrinking with age, helps balance male hormones.
This study found that male hormones help train new immune fighter cells in the thymus gland. When those hormones drop with age, the thymus gets smaller and weaker. Testagen helps keep the hormone signals strong, so more good immune cells get made and the body stays stronger against sickness.
Read the study ↗The role of the thymus-hypothalamus-pituitary-gonadal axis in aging
Findings: Links the immune gland to hormone balance, fights tiredness and weakness from getting older.
Getting older messes up how the brain, immune gland, and sex hormone glands talk to each other. Testagen helps fix that talk, keeping energy and strength up even when age slows things down.
Read the study ↗Evidence that androgens modulate human thymic T cell output
Findings: Boosts new immune cells from the thymus, helps fight sickness better as you age.
Male hormones like testosterone help the thymus send out fresh immune cells. Testagen makes sure those hormones work well, so your body keeps making strong defenders against germs. Testagen acts like a wake-up call for your hormone glands, helping you feel stronger, more energetic, and healthier as you age.
Read the study ↗Identification
Chemistry
- common names
- Testagen, KEDG, Anterior Pituitary Peptide (APP), Anterior pituitary gland-derived tetrapeptide
- cas
- Multiple CAS numbers reported in literature due to different supplier registrations and salt forms
- formula
- C₁₇H₂₉N₅O₉
- molecular weight
- 447.2–447.44 Da (free base)
- source
- Synthetic; rationally designed from amino acid composition analysis of anterior pituitary gland tissue extracts
- biosynthesis
- Nonribosomal synthetic peptide manufactured via solid-phase peptide synthesis
- type
- Linear tetrapeptide; unmodified N and C termini (acetyl or amidated forms may exist in some preparations)
Keep exploring
Related peptides
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Cartalax
AED · Ala-Glu-Asp
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Chonluten
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days